RESEARCH PAGE
![]()
nmTRC Participating Hospitals:
Giselle Sholler, MD
Vermont Children's Hospital
University of Vermont College of Medicine
William Ferguson, MD
Cardinal Glennon Children’s Medical Center
Saint Louis University School of Medicine
William Roberts, MD
Rady Children's Hospital San Diego
UCSD School of Medicine
Peter Zage, MD, PhD
The University of Texas
M.D. Anderson Cancer Center
Joel Kaplan, DO, MPH
Levine Children's Hospital
Deanna Mitchell, MD
Helen DeVos Children’s Hospital
Michigan State University
Jacqueline M Kraveka, DO
Medical University of South Carolina
Don Eslin, MD
Center for Children's Cancer and Blood Disorders
Arnold Palmer Hospital for Children
M. D. Anderson Cancer Center Orlando
~~~~~~~ ~~~~~~ ~~~~~~
Clinical Trials Offered by nmTRC
Nifurtimox for Relapsed or Refractory Neuroblastoma
Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
Trial of TPI 287 as a Single Agent and in Combination With Temozolomide in Patients With Refractory
or Recurrent Neuroblastoma or Medulloblastoma
For more information go to: http://www.nmtrc.org/
http://www.nballiance.org/